Background: Botswana has high HIV prevalence among pregnant women (37.4% in 2003)
and provides free services for prevention of mother-to-child transmission (PMTCT) of HIV …

In many areas of the globe most HIV infection is transmitted sexually or in association with
pregnancy, childbirth and breastfeeding, raising the need for sexual and reproductive health …

Objective The purpose of this guideline is to provide recommendations to obstetric health
care providers and to minimize practice variations for HIV screening, while taking provincial …

Zidovudine (AZT)• Approved by FDA and HPB for use in pregnancy• FDA pregnancy
category C• No documented toxic effects in humans, aside from reversible anemia in …

Background Despite increasing advocacy for an “opt-out” strategy in routine prenatal HIV
screening programs in Canada, no published studies have examined factors that may affect …

OBJECTIVE To examine how prenatal care providers responded to a new provincial policy
of offering HIV testing to all prenatal patients, and to determine factors associated with self …

Data are lacking on factors that may impact conception-related decision-making among
individuals living with HIV. This study's aim was to shed light on these considerations …

Abstract Background Women in Canada, as in the rest of the world, represent an increasing
proportion of new HIV positive cases. 1 In 2002, women accounted for 25% of all positive …

Objective The purpose of this guideline is to provide recommendations to obstetric health
care providers and to minimize practice variations for HIV screening, while taking provincial …

Abstract Objective All Canadian jurisdictions have human immunodeficiency virus (HIV)
testing programs requiring that clinicians discuss HIV testing with all pregnant women and …